Brief: Graphite Bio Reports Fourth Quarter Results

LENZ Therapeutics

20/03/2023 20:08

March 20 (Reuters) - Graphite Bio Inc  GRPH.O :
    * GRAPHITE BIO REPORTS RECENT BUSINESS PROGRESS AND FOURTH
QUARTER
AND FISCAL YEAR 2022 FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.44
    * AS OF DECEMBER 31, 2022, CASH, CASH EQUIVALENTS AND
INVESTMENTS
IN MARKETABLE SECURITIES TOTALED $283.6 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwbzXDJda 
Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))